BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33407364)

  • 1. A Chinese family with Noonan syndrome caused by a heterozygous variant in LZTR1: a case report and literature review.
    Zhao X; Li Z; Wang L; Lan Z; Lin F; Zhang W; Su Z
    BMC Endocr Disord; 2021 Jan; 21(1):2. PubMed ID: 33407364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants.
    Johnston JJ; van der Smagt JJ; Rosenfeld JA; Pagnamenta AT; Alswaid A; Baker EH; Blair E; Borck G; Brinkmann J; Craigen W; Dung VC; Emrick L; Everman DB; van Gassen KL; Gulsuner S; Harr MH; Jain M; Kuechler A; Leppig KA; McDonald-McGinn DM; Can NTB; Peleg A; Roeder ER; Rogers RC; Sagi-Dain L; Sapp JC; Schäffer AA; Schanze D; Stewart H; Taylor JC; Verbeek NE; Walkiewicz MA; Zackai EH; Zweier C; ; Zenker M; Lee B; Biesecker LG
    Genet Med; 2018 Oct; 20(10):1175-1185. PubMed ID: 29469822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome.
    Pagnamenta AT; Kaisaki PJ; Bennett F; Burkitt-Wright E; Martin HC; Ferla MP; Taylor JM; Gompertz L; Lahiri N; Tatton-Brown K; Newbury-Ecob R; Henderson A; Joss S; Weber A; Carmichael J; Turnpenny PD; McKee S; Forzano F; Ashraf T; Bradbury K; Shears D; Kini U; de Burca A; ; Blair E; Taylor JC; Stewart H
    Clin Genet; 2019 Jun; 95(6):693-703. PubMed ID: 30859559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes.
    Umeki I; Niihori T; Abe T; Kanno SI; Okamoto N; Mizuno S; Kurosawa K; Nagasaki K; Yoshida M; Ohashi H; Inoue SI; Matsubara Y; Fujiwara I; Kure S; Aoki Y
    Hum Genet; 2019 Jan; 138(1):21-35. PubMed ID: 30368668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligo-astrocytoma in LZTR1-related Noonan syndrome.
    Jacquinet A; Bonnard A; Capri Y; Martin D; Sadzot B; Bianchi E; Servais L; Sacré JP; Cavé H; Verloes A
    Eur J Med Genet; 2020 Jan; 63(1):103617. PubMed ID: 30664951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LZTR1: Genotype Expansion in Noonan Syndrome.
    Güemes M; Martín-Rivada Á; Ortiz-Cabrera NV; Martos-Moreno GÁ; Pozo-Román J; Argente J
    Horm Res Paediatr; 2019; 92(4):269-275. PubMed ID: 31533111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome.
    Yamamoto GL; Aguena M; Gos M; Hung C; Pilch J; Fahiminiya S; Abramowicz A; Cristian I; Buscarilli M; Naslavsky MS; Malaquias AC; Zatz M; Bodamer O; Majewski J; Jorge AA; Pereira AC; Kim CA; Passos-Bueno MR; Bertola DR
    J Med Genet; 2015 Jun; 52(6):413-21. PubMed ID: 25795793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Providing more evidence on LZTR1 variants in Noonan syndrome patients.
    Chinton J; Huckstadt V; Mucciolo M; Lepri F; Novelli A; Gravina LP; Obregon MG
    Am J Med Genet A; 2020 Feb; 182(2):409-414. PubMed ID: 31825158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.
    Farncombe KM; Thain E; Barnett-Tapia C; Sadeghian H; Kim RH
    BMC Med Genomics; 2022 Jul; 15(1):160. PubMed ID: 35840934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal recessive Noonan-like syndrome caused by homozygosity for a previously unreported variant in SPRED2.
    Markholt S; Andreasen L; Bjerre J; Gregersen PA; Andersen BN
    Eur J Med Genet; 2023 Feb; 66(2):104695. PubMed ID: 36608738
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Jenkins J; Barnes A; Birnbaum B; Papagiannis J; Thiffault I; Saunders CJ
    Circ Genom Precis Med; 2020 Apr; 13(2):e002690. PubMed ID: 32004086
    [No Abstract]   [Full Text] [Related]  

  • 12. Expanding the clinical phenotype of RASopathies in 38 Turkish patients, including the rare LZTR1, RAF1, RIT1 variants, and large deletion in NF1.
    Uludağ Alkaya D; Lissewski C; Yeşil G; Zenker M; Tüysüz B
    Am J Med Genet A; 2021 Dec; 185(12):3623-3633. PubMed ID: 34184824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digenic inheritance of subclinical variants in Noonan Syndrome patients: an alternative pathogenic model?
    Ferrari L; Mangano E; Bonati MT; Monterosso I; Capitanio D; Chiappori F; Brambilla I; Gelfi C; Battaglia C; Bordoni R; Riva P
    Eur J Hum Genet; 2020 Oct; 28(10):1432-1445. PubMed ID: 32514133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Noonan Syndrome Gene
    Sewduth RN; Pandolfi S; Steklov M; Sheryazdanova A; Zhao P; Criem N; Baietti MF; Lechat B; Quarck R; Impens F; Sablina AA
    Circ Res; 2020 May; 126(10):1379-1393. PubMed ID: 32175818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noonan syndrome-associated biallelic LZTR1 mutations cause cardiac hypertrophy and vascular malformations in zebrafish.
    Nakagama Y; Takeda N; Ogawa S; Takeda H; Furutani Y; Nakanishi T; Sato T; Hirata Y; Oka A; Inuzuka R
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1107. PubMed ID: 31883238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Novel Cases of Autosomal Recessive Noonan Syndrome Associated With LZTR1 Variants.
    Perin F; Trujillo-Quintero JP; Jimenez-Jaimez J; Rodríguez-Vázquez Del Rey MDM; Monserrat L; Tercedor L
    Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):978-980. PubMed ID: 31182298
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular autopsy and clinical family screening in a case of sudden cardiac death reveals ACTN2 mutation related to hypertrophic/dilated cardiomyopathy and a novel LZTR1 variant associated with Noonan syndrome.
    Kraoua L; Jaouadi H; Allouche M; Achour A; Kaouther H; Ahmed HB; Chaker L; Maazoul F; Ouarda F; Zaffran S; M'rad R
    Mol Genet Genomic Med; 2022 Jul; 10(7):e1954. PubMed ID: 35656879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadal dysfunction in a man with Noonan syndrome from the
    Orsolini F; Pignata L; Baldinotti F; Romano S; Tonacchera M; Canale D
    Front Endocrinol (Lausanne); 2024; 15():1354699. PubMed ID: 38689733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling.
    Motta M; Fidan M; Bellacchio E; Pantaleoni F; Schneider-Heieck K; Coppola S; Borck G; Salviati L; Zenker M; Cirstea IC; Tartaglia M
    Hum Mol Genet; 2019 Mar; 28(6):1007-1022. PubMed ID: 30481304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in genetic diagnosis, co-occurrence of 22q11.2 deletion syndrome and Noonan syndrome.
    Chinton J; Huckstadt V; Foncuberta ME; Perez MM; Bonetto MC; Gravina LP; Obregon MG
    Am J Med Genet A; 2022 Aug; 188(8):2505-2508. PubMed ID: 35689529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.